Consuming three or more glasses of liquor per day may raise the risk of pancreatic cancer, but even heavier drinking (seven or more alcoholic beverages per day) has been exonerated as a factor in two forms of esophageal cancer.
Certain DNA sequences were never suspected of having a role in cancer—until now. Cells in the most common type of solid tumor have now been found to feature massive overexpression of these sequences.
Researchers have identified a protein that may aid in developing an effective treatment option for pancreatic cancer, according to a study published in the Journal of Biological Chemistry (2010;285[45]:34729-34740).
Pancreatic cancer metastasizes in the later stages of tumor development, according to a study published in the journal Nature.
Molecular differences in metastatic pancreatic cancer may help identify prognosis for patients, according to a study published in the Public Library of Science Medicine (2010 Jul 13;7(7):e1000307).
Patients with pancreatic cancer may benefit from therapy that combines a cancer medication and an organic compound found in broccoli, according to a study published in Cancer Research (2010 Jun 15;70(12):5004-13).
Patients with initially unresectable pancreatic cancer might experience clinical benefits from neoadjuvant therapy, according to a study published in PLoS Medicine (2010 Apr 20;7(4):e1000267).
People who consume soft drinks increase their risk of developing pancreatic cancer compared with those who do not consume soft drinks, according to a study published in Cancer Epidemiology, Biomarkers & Prevention (February 2010;19[2]:447-455).
Resistance to chemotherapy is one of the greatest challenges in pancreatic cancer treatment. However, US researchers have found that inhibiting the enzyme TAK-1 can overcome this.
Reviews the etiology, diagnosis, treatment, and palliative care associated with pancreatic cancer
